ES2182074T3 - Purificacion de peptidos de la leche, activos biologicamente. - Google Patents
Purificacion de peptidos de la leche, activos biologicamente.Info
- Publication number
- ES2182074T3 ES2182074T3 ES97923643T ES97923643T ES2182074T3 ES 2182074 T3 ES2182074 T3 ES 2182074T3 ES 97923643 T ES97923643 T ES 97923643T ES 97923643 T ES97923643 T ES 97923643T ES 2182074 T3 ES2182074 T3 ES 2182074T3
- Authority
- ES
- Spain
- Prior art keywords
- milk
- purification
- biologically active
- permeate
- procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/832—Milk; colostrum
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE DESCRIBE UN PROCEDIMIENTO PARA SEPARAR UN COMPONENTE LACTEO SOLUBLE DE LA LECHE (POR EJEMPLO, EN UN SISTEMA DE EXTRACCION CONTINUA EN CIRCUITO CERRADO). EL PROCEDIMIENTO COMPRENDE LA UTILIZACION DE FILTRACION DE FLUJO TANGENCIAL A TRAVES DE UNA MEMBRANA PARA FORMAR UN RETENTIVO Y UN PERMEATO, SOMETIENDO EL PERMEATO A UN DISPOSITIVO CAPTOR PARA EXTRAER BASICAMENTE EL COMPONENTE LACTEO SOLUBLE, COMBINANDO EL EFLUENTE DEL DISPOSITIVO CAPTOR CON LA MUESTRA DE LECHE ORIGINAL (RETENTIVO) Y CONTINUAR ESTE PROCEDIMIENTO HASTA QUE LA LECHE SE HA PURIFICADO SUFICIENTEMENTE. PREFERIBLEMENTE, LA LECHE SE COMBINA CON UN AGENTE QUELANTE, TAL COMO EDTA, PARA MEJORAR LA EFICIENCIA DE LA PURIFICACION. ESTE PROCEDIMIENTO ES UTILIZADO VENTAJOSAMENTE CON LA LECHE PROCEDENTE DE ANIMALES TRANSGENICOS QUE HAN SIDO GENETICAMENTE ALTERADOS PARA EXPRESAR PROTEINAS EXOGENAS, TALES COMO PROTEINAS TERAPEUTICAS, EN SU LECHE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/648,235 US6268487B1 (en) | 1996-05-13 | 1996-05-13 | Purification of biologically active peptides from milk |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2182074T3 true ES2182074T3 (es) | 2003-03-01 |
Family
ID=24599969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97923643T Expired - Lifetime ES2182074T3 (es) | 1996-05-13 | 1997-05-13 | Purificacion de peptidos de la leche, activos biologicamente. |
Country Status (14)
Country | Link |
---|---|
US (1) | US6268487B1 (es) |
EP (1) | EP0923308B1 (es) |
JP (1) | JP4476362B2 (es) |
AT (1) | ATE224145T1 (es) |
AU (1) | AU725993B2 (es) |
CA (1) | CA2254871C (es) |
DE (2) | DE122007000008I2 (es) |
DK (1) | DK0923308T3 (es) |
ES (1) | ES2182074T3 (es) |
LU (1) | LU91305I2 (es) |
NL (1) | NL300256I2 (es) |
NZ (1) | NZ332916A (es) |
PT (1) | PT923308E (es) |
WO (1) | WO1997042835A1 (es) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE122007000007I1 (de) | 1986-04-09 | 2007-05-16 | Genzyme Corp | Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern |
AP1678A (en) | 1997-10-20 | 2006-11-27 | Gtc Biotherapeutics Inc | Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems. |
SE9802213D0 (sv) * | 1998-06-18 | 1998-06-18 | Amersham Pharm Biotech Ab | A method for the removal/purification of serum albumins and means for use in the method |
US20030005468A1 (en) * | 1998-06-19 | 2003-01-02 | Meade Harry M. | Methods and vectors for improving nucleic acid expression |
AU6104799A (en) * | 1998-09-24 | 2000-04-10 | Ppl Therapeutics (Scotland) Limited | Purification of fibrinogen from fluids by precipitation and hydrophoic chromatography |
DK1148779T3 (da) * | 1999-01-06 | 2008-03-25 | Merrimack Pharmaceuticals Inc | Ekspression af secerneret humant alpha-fötoprotein i transgene dyr |
EP1194570A1 (en) | 1999-06-23 | 2002-04-10 | PPL Therapeutics (Scotland) Limited | Fusion proteins incorporating lysozyme |
WO2001085192A1 (en) * | 2000-05-05 | 2001-11-15 | Gtc Biotherapeutics, Inc. | Transgenically produced decorin |
US20030195707A1 (en) * | 2000-05-25 | 2003-10-16 | Schork Nicholas J | Methods of dna marker-based genetic analysis using estimated haplotype frequencies and uses thereof |
US20020077775A1 (en) * | 2000-05-25 | 2002-06-20 | Schork Nicholas J. | Methods of DNA marker-based genetic analysis using estimated haplotype frequencies and uses thereof |
US20040226053A1 (en) * | 2000-10-13 | 2004-11-11 | Meade Harry M. | Methods of producing a target molecule in a transgenic animal and purification of the target molecule |
CN1525977A (zh) * | 2001-06-13 | 2004-09-01 | 陶洛斯Hsa有限责任公司 | 人血清白蛋白的纯化 |
US7285631B2 (en) * | 2001-08-10 | 2007-10-23 | Serono Genetics Institute S.A. | Human cDNAs and proteins and uses thereof |
US6875459B2 (en) * | 2001-09-10 | 2005-04-05 | Henry B. Kopf | Method and apparatus for separation of milk, colostrum, and whey |
US20060253913A1 (en) * | 2001-12-21 | 2006-11-09 | Yue-Jin Huang | Production of hSA-linked butyrylcholinesterases in transgenic mammals |
WO2003090545A1 (en) * | 2002-04-24 | 2003-11-06 | Dairy Development Specialists, Inc. | Intermediate ingredient for dairy product manufacturing and method of making the same |
EP1367065B1 (en) * | 2002-05-27 | 2008-07-30 | Nestec S.A. | Acid soluble proteins from micellar casein |
GB0216001D0 (en) * | 2002-07-10 | 2002-08-21 | Nat Blood Authority | Process and composition |
US20040092719A1 (en) * | 2002-09-17 | 2004-05-13 | Eszter Birck-Wilson | Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds |
JP2006507839A (ja) * | 2002-11-27 | 2006-03-09 | ジーティーシー バイオセラピューティックス インコーポレイテッド | 乳中に安定して産生される改変抗体およびその製造方法 |
US20040231010A1 (en) * | 2003-01-09 | 2004-11-18 | Murray James D. | Lysozyme transgenic ungulates |
US20040210953A1 (en) * | 2003-01-09 | 2004-10-21 | Murray James D. | Lysozyme transgenic ungulates |
US20040248262A1 (en) | 2003-01-22 | 2004-12-09 | Koeberl Dwight D. | Constructs for expressing lysomal polypeptides |
RU2005129745A (ru) * | 2003-02-24 | 2006-03-20 | Джитиси Байотерапьютикс, Инк. (Us) | Способы и устройство проточной фильтрации вдоль потока |
US7125963B2 (en) * | 2004-03-03 | 2006-10-24 | En N Tech Inc | Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions |
US20050197496A1 (en) * | 2004-03-04 | 2005-09-08 | Gtc Biotherapeutics, Inc. | Methods of protein fractionation using high performance tangential flow filtration |
US20050245444A1 (en) * | 2004-04-30 | 2005-11-03 | Yann Echelard | Method of using recombinant human antithrombin for neurocognitive disorders |
US20060121004A1 (en) * | 2004-12-07 | 2006-06-08 | Yann Echelard | Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin |
US20060130159A1 (en) * | 2004-12-09 | 2006-06-15 | Nick Masiello | Method of purifying recombinant MSP 1-42 derived from Plasmodium falciparum |
US20080019905A9 (en) * | 2005-02-18 | 2008-01-24 | Strome Scott E | Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection |
WO2006138647A2 (en) * | 2005-06-16 | 2006-12-28 | Gtc Biotherapeutics, Inc. | Method of making recombinant human antibodies for use in biosensor technology |
WO2007014244A2 (en) * | 2005-07-25 | 2007-02-01 | Gtc Biotherapeutics, Inc. | Method of purifying recombinant human antithrombin to enhance the viral and prion safety profile |
EP2388272A1 (en) * | 2005-10-21 | 2011-11-23 | GTC Biotherapeutics, Inc. | Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use |
US7531632B2 (en) * | 2006-02-16 | 2009-05-12 | Gtc Biotherapeutics, Inc. | Clarification of transgenic milk using depth filtration |
FR2901707B1 (fr) | 2006-05-31 | 2017-09-29 | Lab Francais Du Fractionnement | Composition de facteur vii recombinant ou transgenique, chaque molecule de facteur vii possedant deux sites de n-glycosylation a motifs glycanniques definis |
US20090208480A1 (en) * | 2006-08-04 | 2009-08-20 | Yue Huang | Long half-life recombinant butyrylcholinesterase |
FR2910786B1 (fr) * | 2006-12-29 | 2017-08-11 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies (Lfb) | "procede d'extraction d'une proteine presente dans du lait" |
JP5208428B2 (ja) * | 2007-01-30 | 2013-06-12 | 雪印メグミルク株式会社 | 美肌剤 |
FR2912310B1 (fr) | 2007-02-13 | 2009-08-07 | Kasan Sarl | Nouvelles compositions cosmetiques et/ou pharmaceutiques et leurs applications. |
NZ583234A (en) | 2007-07-10 | 2012-06-29 | Glanbia Nutritionals | Method for removing endotoxin from proteins |
TWI346666B (en) * | 2007-12-31 | 2011-08-11 | Animal Technology Inst Taiwan | Method for seperating casein from casein-contained solution |
EP2077273B1 (en) | 2007-12-31 | 2011-09-14 | Animal Technology Institute Taiwan | Methods for separating casein from soluble proteins in a composition |
US8304005B2 (en) * | 2008-04-21 | 2012-11-06 | Fuji Oil Company, Limited | Method for production of defatted soymilk peptide |
EP2279003A4 (en) * | 2008-05-01 | 2013-04-03 | Gtc Biotherapeutics Inc | ANTI-CD137 ANTIBODY AS A MEANS FOR THE TREATMENT OF INFLAMMATORY DISEASES |
US9247766B2 (en) * | 2008-05-14 | 2016-02-02 | Murray Goulburn Co-Operative Co., Limited | Angiogenin-enriched milk fractions |
SG10201407983VA (en) * | 2009-12-18 | 2015-01-29 | Csl Ltd | Method of purifying polypeptides |
AU2010340358B2 (en) | 2009-12-21 | 2014-07-24 | Pharmathene, Inc. | Recombinant butyrylcholinesterases and truncates thereof |
US8861162B2 (en) * | 2010-03-09 | 2014-10-14 | Honeywell International Inc. | High power solid state power controller (SSPC) solution for primary power distribution applications |
FR2958496A1 (fr) * | 2010-04-09 | 2011-10-14 | Bioprotein Technologies Sa | Preparation de proteine plasmatique de transfert des phospholipides (pltp) humaine recombinante a partir du lait d'animaux transgeniques. |
CN103002878B (zh) | 2010-04-09 | 2015-07-01 | 帕西拉制药有限公司 | 用于配制大直径合成膜囊泡的方法 |
WO2012045769A1 (en) | 2010-10-05 | 2012-04-12 | Novo Nordisk Health Care Ag | Process for protein production |
SG191781A1 (en) | 2010-12-30 | 2013-08-30 | Lab Francais Du Fractionnement | Glycols as pathogen inactivating agents |
EP2694196B1 (en) | 2011-04-01 | 2021-07-21 | EMD Millipore Corporation | Nanofiber containing composite structures |
AU2012278836B2 (en) * | 2011-07-07 | 2016-03-10 | Lfb Usa, Inc. | Formulations that stabilize proteins |
TW201400499A (zh) | 2012-03-12 | 2014-01-01 | Revo Biolog Inc | 抗凝血酶用於治療妊娠毒血症之用途 |
EP2687595B1 (en) | 2012-07-19 | 2018-05-30 | Laboratoire Français du Fractionnement et des Biotechnologies | Method for purifying transgenic factor VII |
WO2014022748A1 (en) | 2012-08-03 | 2014-02-06 | Revo Biologics, Inc. | The use of antithrombin in extracorporeal membrane oxygenation |
CA2900909A1 (en) | 2013-02-13 | 2014-08-21 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Highly galactosylated anti-tnf-.alpha. antibodies and uses thereof |
CN105263319A (zh) | 2013-02-13 | 2016-01-20 | 法国化学与生物科技实验室 | 具有经修饰的糖基化的蛋白及其生产方法 |
PL3016729T3 (pl) | 2013-07-05 | 2020-09-07 | Laboratoire Français Du Fractionnement Et Des Biotechnologies Société Anonyme | Matryca do chromatografii powinowactwa |
US9661868B2 (en) * | 2013-07-16 | 2017-05-30 | Mead Johnson Nutrition Company | Expanded bed adsorption methods for isolation of basic milk proteins including lactoferrin |
JP2017520531A (ja) * | 2014-06-02 | 2017-07-27 | ラボラトワール フランセ デュ フラクショヌマン エ デ ビオテクノロジーLaboratoire Francais du Fractionnement et des Biotechnologies | Fc断片の産生 |
FR3034419B1 (fr) | 2015-04-02 | 2017-12-15 | Lab Francais Du Fractionnement | Procede de purification d'une proteine recombinante therapeutique a partir d'un lait transgenique |
JP6786519B2 (ja) * | 2015-04-17 | 2020-11-18 | イー・エム・デイー・ミリポア・コーポレイシヨン | 接線流濾過モードで作動するナノファイバー限外濾過膜を用いた、試料中の目的の生物学的物質を精製する方法 |
EP3805257A4 (en) * | 2018-05-24 | 2022-03-16 | Jiangsu Hengrui Medicine Co., Ltd. | METHOD OF PRODUCTION OF A PRECURSOR OF RECOMBINANT HUMAN INSULIN OR ANALOGUE THEREOF |
FR3082427B1 (fr) | 2018-06-14 | 2020-09-25 | Lab Francais Du Fractionnement | Combinaison de facteur vii et d'un anticorps bispecifique anti-facteurs ix et x |
WO2022024828A1 (ja) | 2020-07-29 | 2022-02-03 | 和弘 原 | 成分調整物生産装置及び成分調整物生産方法 |
CN113101737B (zh) * | 2021-03-04 | 2023-09-15 | 京美生命科技(杭州)有限公司 | 一种亲和切向流过滤系统及其构建方法和外泌体提取方法及应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2459619B1 (fr) | 1979-06-26 | 1983-07-29 | Agronomique Inst Nat Rech | Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede |
FR2487642B2 (fr) | 1980-07-31 | 1985-10-18 | Bel Fromageries | Procede de preparation de fractions proteiques par ultrafiltration et chromatographie d'exclusion et d'echange d'ions |
DE3432718C1 (de) | 1984-09-06 | 1986-05-22 | Biotest Pharma GmbH, 6000 Frankfurt | Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen |
FR2584727B1 (fr) | 1985-07-11 | 1988-06-17 | Roussel Uclaf | Procede d'extraction de proteines du lait, produits, application du procede, et compositions pharmaceutiques |
JPS62298536A (ja) | 1986-06-17 | 1987-12-25 | Green Cross Corp:The | 生理活性物質の自動精製方法および自動精製装置 |
DE3743440A1 (de) * | 1987-12-21 | 1989-06-29 | Gauri Kailash Kumar | Verfahren zum trennen der geloesten und ungeloesten bestandteile von milch |
US4897465A (en) | 1988-10-12 | 1990-01-30 | Abbott Laboratories | Enrichment and concentration of proteins by ultrafiltration |
CA2351200A1 (en) | 1989-12-01 | 1991-06-13 | Gene Pharming Europe Bv | Production of recombinant polypeptides by bovine species and transgenic methods |
NL9001650A (nl) | 1990-07-19 | 1992-02-17 | Ver Coop Melkind | Werkwijze voor de bereiding van een melkeiwit-isolaat. |
US5256294A (en) * | 1990-09-17 | 1993-10-26 | Genentech, Inc. | Tangential flow filtration process and apparatus |
US5175013A (en) | 1990-12-31 | 1992-12-29 | The Pillsbury Company | Frozen dessert compositions and products |
US5178894A (en) | 1991-09-26 | 1993-01-12 | Silvia P. Rudel | High non-fat milk content bread products having improved keeping qualities |
JP3670003B2 (ja) | 1992-06-15 | 2005-07-13 | ファーミング ビー.ブイ. | ウシ種による組み換えポリペプチドの製造及びトランスジェニック法 |
US5256437A (en) * | 1992-06-19 | 1993-10-26 | Pall Corporation | Product and process of making sterile milk through dynamic microfiltration |
AU693436B2 (en) | 1993-03-09 | 1998-07-02 | Genzyme Corporation | Isolation of components of interest from milk |
WO1995022258A2 (en) | 1994-02-16 | 1995-08-24 | Pharming Bv | Isolation of lactoferrin from milk |
US5597486A (en) * | 1995-05-01 | 1997-01-28 | Millipore Investment Holdings Limited | Membrane filtration with optimized addition of second liquid to maximize flux |
-
1996
- 1996-05-13 US US08/648,235 patent/US6268487B1/en not_active Expired - Lifetime
-
1997
- 1997-05-13 ES ES97923643T patent/ES2182074T3/es not_active Expired - Lifetime
- 1997-05-13 JP JP54103697A patent/JP4476362B2/ja not_active Expired - Lifetime
- 1997-05-13 DE DE122007000008C patent/DE122007000008I2/de active Active
- 1997-05-13 CA CA002254871A patent/CA2254871C/en not_active Expired - Lifetime
- 1997-05-13 AT AT97923643T patent/ATE224145T1/de active
- 1997-05-13 NZ NZ332916A patent/NZ332916A/xx not_active IP Right Cessation
- 1997-05-13 DK DK97923643T patent/DK0923308T3/da active
- 1997-05-13 DE DE69715641T patent/DE69715641T2/de not_active Expired - Lifetime
- 1997-05-13 EP EP97923643A patent/EP0923308B1/en not_active Expired - Lifetime
- 1997-05-13 AU AU29402/97A patent/AU725993B2/en not_active Expired
- 1997-05-13 PT PT97923643T patent/PT923308E/pt unknown
- 1997-05-13 WO PCT/US1997/008044 patent/WO1997042835A1/en active IP Right Grant
-
2007
- 2007-01-12 LU LU91305C patent/LU91305I2/fr unknown
- 2007-01-19 NL NL300256C patent/NL300256I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
DE122007000008I1 (de) | 2009-05-20 |
EP0923308B1 (en) | 2002-09-18 |
AU725993B2 (en) | 2000-10-26 |
JP2000510701A (ja) | 2000-08-22 |
CA2254871C (en) | 2008-03-25 |
PT923308E (pt) | 2002-11-29 |
EP0923308A4 (es) | 1999-06-30 |
LU91305I2 (fr) | 2007-03-12 |
ATE224145T1 (de) | 2002-10-15 |
DE122007000008I2 (de) | 2011-01-13 |
NZ332916A (en) | 2000-05-26 |
WO1997042835A1 (en) | 1997-11-20 |
AU2940297A (en) | 1997-12-05 |
DK0923308T3 (da) | 2002-10-14 |
EP0923308A1 (en) | 1999-06-23 |
CA2254871A1 (en) | 1997-11-20 |
NL300256I1 (nl) | 2007-04-02 |
US6268487B1 (en) | 2001-07-31 |
DE69715641D1 (de) | 2002-10-24 |
NL300256I2 (nl) | 2007-09-03 |
JP4476362B2 (ja) | 2010-06-09 |
DE69715641T2 (de) | 2003-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2182074T3 (es) | Purificacion de peptidos de la leche, activos biologicamente. | |
ATE373010T1 (de) | Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen | |
TR199901840T2 (xx) | DNA'nın cross-flow-filtrasyonu ile temizlenmesi. | |
ES2156602T3 (es) | Expresion de albumina en levaduras. | |
DK426386A (da) | Fremgangsmaade til rensning og aktivering af proteiner fra uoploeselige inklusionslegemer | |
DE69535314D1 (de) | Modifizierte pflanzenviren als vektore für heterologe peptide | |
ATE310017T1 (de) | Verfahren zur reinigung und isolierung von wasserlöslichen peptiden und proteinen aus pflanzenquellen | |
RU2007110534A (ru) | Способ концентрирования препаратов антител | |
DE69400874D1 (de) | Verfahren zur herstellung von keramischen hohlfasermembranen zur mikorfiltration, ultrafiltration und gastrennung | |
ATE278785T1 (de) | Neues verfahren zur gewinnung und reinigung von fusionsproteinen | |
MY126838A (en) | Purification of protein inclusion bodies by crossflow microfiltration. | |
DE3789309D1 (de) | Enzymatische membran, verfahren zur herstellung und trennung von peptiden. | |
TR200003658T2 (tr) | Su arıtma cihazı ve metodu | |
DE69815688D1 (de) | Verfahren zur hohlfasern filtration | |
NO951750L (no) | Renset "nontypable" Haemophilus influenzae P5 protein som en vaksine for "nontypable" Haemophilus influenzae stamme | |
DE3786708D1 (de) | Verfahren zur gewinnung aktiver proteine aus einer biologisch inaktiven form. | |
DK0787007T3 (da) | Antiinflammatorisk faktor, isoleringsfremgangsmåde og anvendelse | |
ATE82471T1 (de) | Verfahren zur abtrennung bestimmter proteine aus molke. | |
DE3882154T2 (de) | Verfahren zur Herstellung des pres 1/S2/S-Hepatitis-B-Antigens aus Hefe. | |
ATE91709T1 (de) | Verfahren zur entfernung unerwuenschter zellen aus menschlichen lymphozytenpopulationen, anwendung des verfahrens zur herstellung monoklonaler antikoerper und dafuer geeigneter kit. |